Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics

Anesthesia and Analgesia

Volumn 91, Issue 5, 2000, Pages 1250-1255

  Jellish, W Scott ^a   Brody, Michael ^a   Sawicki, Kristina ^a   Slogoff, Stephen ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; FENTANYL; ISOFLURANE; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; ROCURONIUM;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; BRAIN SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MUSCLE RELAXATION; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033762659     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200011000-00037     Document Type: Article

References (20)

1. The pharmacodynamics and pharmacokinetics of Org 9426, a new nondepolarizing neuromuscular blocking agent, in patients anesthetized with nitrous oxide and halothane
2. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
3. Comparative clinical pharmacology of rocuronium, cisatracurium and their combination
4. Neuromuscular blocking effects and train of four fade with cisatracurium: Comparison with other nondepolarizing relaxants
5. Pharmacodynamic and pharmakokinetics of rocuronium following continuous infusion in patients during intravenous anesthesia
6. A comparison of cisatracurium and atracurium: Onset of neuromuscular block after bolus injection and recovery after subsequent infusion
7. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia
8. Continuous intravenous infusion of rocuronium (ORG 9426) in patients receiving balanced enflurane or isoflurane anesthesia
9. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans
10. Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anesthesia
11. Cumulation and reversal with prolonged infusion of atracurium and vecuronium
12. Spontaneous recovery of residual neuromuscular blockade after atracurium or vecuronium during isoflurane anaesthesia
13. Neuromuscular effects of rocuronium during sevoflurane, isoflurane and intravenous anesthesia
14. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation
15. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients
16. Importance of the organ-independent elimination of cisatracurium
17. A new method for studying the relationship between hepatic uptake of drugs and their pharmacodynamic effects in anaesthetized cats
18. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants
19. Acute and chronic changes in intra-and extracellular potassium and responses to neuromuscular blocking agents
20. Quantitation of the interaction of rocuronium bromide with etomidate, fentanyl, midazolam, propofol, thiopentone and isoflurane using closed-loop feedback control of infusion of rocuronium